false Q2 0001584549 --12-31 2023-06-30
2024-02-29 2024-02-29 P5Y9M18D P1M6D P6Y10M20D P9Y7M2D P7M2D
P6Y10M2D P5Y3M14D 0001584549 2022-01-01 2022-06-30 xbrli:shares
0001584549 2022-08-09 iso4217:USD 0001584549 2022-06-30 0001584549
2021-12-31 iso4217:USD xbrli:shares 0001584549 2022-04-01
2022-06-30 0001584549 2021-04-01 2021-06-30 0001584549 2021-01-01
2021-06-30 0001584549 us-gaap:CommonStockMember 2022-03-31
0001584549 us-gaap:AdditionalPaidInCapitalMember 2022-03-31
0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-03-31 0001584549 us-gaap:RetainedEarningsMember 2022-03-31
0001584549 2022-03-31 0001584549
us-gaap:NoncontrollingInterestMember 2022-03-31 0001584549
us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001584549
us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30
0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-04-01 2022-06-30 0001584549 us-gaap:RetainedEarningsMember
2022-04-01 2022-06-30 0001584549
us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30
0001584549 us-gaap:CommonStockMember 2022-06-30 0001584549
us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001584549
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30
0001584549 us-gaap:RetainedEarningsMember 2022-06-30 0001584549
us-gaap:NoncontrollingInterestMember 2022-06-30 0001584549
us-gaap:CommonStockMember 2021-03-31 0001584549
us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001584549
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31
0001584549 us-gaap:RetainedEarningsMember 2021-03-31 0001584549
2021-03-31 0001584549 us-gaap:CommonStockMember 2021-04-01
2021-06-30 0001584549 us-gaap:AdditionalPaidInCapitalMember
2021-04-01 2021-06-30 0001584549
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01
2021-06-30 0001584549 us-gaap:RetainedEarningsMember 2021-04-01
2021-06-30 0001584549 us-gaap:CommonStockMember 2021-06-30
0001584549 us-gaap:AdditionalPaidInCapitalMember 2021-06-30
0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-06-30 0001584549 us-gaap:RetainedEarningsMember 2021-06-30
0001584549 2021-06-30 0001584549 us-gaap:CommonStockMember
2021-12-31 0001584549 us-gaap:AdditionalPaidInCapitalMember
2021-12-31 0001584549
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31
0001584549 us-gaap:RetainedEarningsMember 2021-12-31 0001584549
us-gaap:NoncontrollingInterestMember 2021-12-31 0001584549
us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001584549
us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30
0001584549 us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-01-01 2022-06-30 0001584549 us-gaap:RetainedEarningsMember
2022-01-01 2022-06-30 0001584549
us-gaap:NoncontrollingInterestMember 2022-01-01 2022-06-30
0001584549 us-gaap:CommonStockMember 2020-12-31 0001584549
us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001584549
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31
0001584549 us-gaap:RetainedEarningsMember 2020-12-31 0001584549
2020-12-31 0001584549 us-gaap:CommonStockMember 2021-01-01
2021-06-30 0001584549 us-gaap:AdditionalPaidInCapitalMember
2021-01-01 2021-06-30 0001584549
us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01
2021-06-30 0001584549 us-gaap:RetainedEarningsMember 2021-01-01
2021-06-30 xbrli:pure 0001584549
vff:RoseLifeScienceIncorporationMember 2022-06-30 0001584549
us-gaap:PublicUtilitiesInventoryRawMaterialsMember
vff:CannabisBusinessMember 2022-06-30 0001584549
us-gaap:PublicUtilitiesInventoryRawMaterialsMember
vff:CannabisBusinessMember 2021-12-31 0001584549
vff:PublicUtilitiesInventoryWorkInProgressMember
vff:CannabisBusinessMember 2022-06-30 0001584549
vff:PublicUtilitiesInventoryWorkInProgressMember
vff:CannabisBusinessMember 2021-12-31 0001584549
vff:PublicUtilitiesInventoryFinishedGoodsMember
vff:CannabisBusinessMember 2022-06-30 0001584549
vff:PublicUtilitiesInventoryFinishedGoodsMember
vff:CannabisBusinessMember 2021-12-31 0001584549
vff:PublicUtilitiesInventoryPackagingMember
vff:CannabisBusinessMember 2022-06-30 0001584549
vff:PublicUtilitiesInventoryPackagingMember
vff:CannabisBusinessMember 2021-12-31 0001584549
vff:CropInventoryMember vff:ProduceAndEnergyMember 2022-06-30
0001584549 vff:CropInventoryMember vff:ProduceAndEnergyMember
2021-12-31 0001584549 vff:PurchasedProduceMember
vff:ProduceAndEnergyMember 2022-06-30 0001584549
vff:PurchasedProduceMember vff:ProduceAndEnergyMember 2021-12-31
0001584549 vff:SparePartsInventoryAndPackagingMember
vff:ProduceAndEnergyMember 2022-06-30 0001584549
vff:SparePartsInventoryAndPackagingMember
vff:ProduceAndEnergyMember 2021-12-31 0001584549 us-gaap:LandMember
2022-06-30 0001584549 us-gaap:LandMember 2021-12-31 0001584549
us-gaap:LeaseholdsAndLeaseholdImprovementsMember 2022-06-30
0001584549 us-gaap:LeaseholdsAndLeaseholdImprovementsMember
2021-12-31 0001584549 us-gaap:BuildingMember 2022-06-30 0001584549
us-gaap:BuildingMember 2021-12-31 0001584549
us-gaap:MachineryAndEquipmentMember 2022-06-30 0001584549
us-gaap:MachineryAndEquipmentMember 2021-12-31 0001584549
us-gaap:ConstructionInProgressMember 2022-06-30 0001584549
us-gaap:ConstructionInProgressMember 2021-12-31 0001584549
vff:CannabisBusinessMember country:CA 2021-12-31 0001584549
vff:CannabisBusinessMember country:US 2021-12-31 0001584549
vff:CannabisBusinessMember country:CA 2022-01-01 2022-06-30
0001584549 vff:CannabisBusinessMember country:US 2022-01-01
2022-06-30 0001584549 vff:CannabisBusinessMember country:CA
2022-06-30 0001584549 vff:CannabisBusinessMember country:US
2022-06-30 0001584549 us-gaap:LicensingAgreementsMember 2022-06-30
0001584549 us-gaap:LicensingAgreementsMember 2021-12-31 0001584549
vff:BrandAndTrademarksMember 2022-06-30 0001584549
vff:BrandAndTrademarksMember 2021-12-31 0001584549
us-gaap:ComputerSoftwareIntangibleAssetMember 2022-06-30 0001584549
us-gaap:ComputerSoftwareIntangibleAssetMember 2021-12-31 0001584549
vff:OtherMember 2022-06-30 0001584549 vff:OtherMember 2021-12-31
0001584549 vff:OperatingLeasesMember 2022-06-30 0001584549
vff:RoseAcquisitionMember 2021-11-15 2021-11-15 0001584549
vff:RoseAcquisitionMember 2021-11-15 iso4217:CAD 0001584549
vff:RoseAcquisitionMember us-gaap:CommonStockMember 2021-11-15
0001584549 vff:RoseAcquisitionMember
vff:ManagementShareholdersMember 2021-11-15 vff:CoFounder
0001584549 vff:RoseAcquisitionMember us-gaap:CallOptionMember
2021-11-15 0001584549 vff:LeliHollandBVMember
vff:OptionAgreementMember 2021-09-01 2021-09-30 iso4217:EUR
0001584549 vff:LeliHollandBVMember vff:OptionAgreementMember
2021-09-30 0001584549 vff:LLLichtendahlBeheerBVMember 2022-03-18
0001584549 vff:LLLichtendahlBeheerBVMember 2022-03-18 2022-03-18
0001584549 vff:VillageFieldsHempUSALLCMember 2022-04-01 2022-06-30
0001584549 vff:VillageFieldsHempUSALLCMember 2021-04-01 2021-06-30
0001584549 vff:VillageFieldsHempUSALLCMember 2022-01-01 2022-06-30
0001584549 vff:VillageFieldsHempUSALLCMember 2021-01-01 2021-06-30
0001584549 vff:TermLoanFCCLoanMember 2022-01-01 2022-06-30
0001584549 vff:TermLoanFCCLoanMember 2021-01-01 2021-12-31
0001584549 vff:TermLoanVFCEMember 2021-01-01 2021-12-31 0001584549
vff:TermLoanOneMember vff:PureSunfarmsMember 2022-01-01 2022-06-30
0001584549 vff:TermLoanOneMember vff:PureSunfarmsMember 2021-01-01
2021-12-31 0001584549 vff:TermLoanTwoMember vff:PureSunfarmsMember
2022-01-01 2022-06-30 0001584549 vff:TermLoanTwoMember
vff:PureSunfarmsMember 2021-01-01 2021-12-31 0001584549
vff:BDCFacilityMember vff:PureSunfarmsMember 2022-01-01 2022-06-30
0001584549 vff:BDCFacilityMember vff:PureSunfarmsMember 2021-01-01
2021-12-31 0001584549 2021-01-01 2021-12-31 0001584549
vff:TermLoanVFCEMember 2022-01-01 2022-06-30 0001584549
vff:BDCLoanMember vff:PureSunfarmsMember 2022-01-01 2022-06-30
0001584549 vff:RevolvingOperatingLoanMember 2022-01-01 2022-06-30
0001584549 vff:RevolvingOperatingLoanMember 2021-01-01 2021-12-31
0001584549
vff:TwoThousandTwentyOneNonRevolvingVariableRateTermLoanMember
vff:CanadianCreditorMember 2022-06-30 0001584549
vff:TwoThousandTwentyOneNonRevolvingVariableRateTermLoanMember
vff:CanadianCreditorMember 2021-12-31 0001584549
vff:RevolvingOperatingLoanMember 2022-06-30 0001584549
vff:RevolvingOperatingLoanMember 2021-12-31 0001584549
vff:PureSunfarmsMember vff:RevolvingOperatingLoanMember 2022-06-30
0001584549 vff:PureSunfarmsMember vff:RevolvingOperatingLoanMember
2021-12-31 0001584549 vff:PureSunfarmsMember
us-gaap:LetterOfCreditMember 2022-06-30 0001584549
vff:PureSunfarmsMember us-gaap:LetterOfCreditMember 2021-12-31
0001584549 us-gaap:AccountsPayableAndAccruedLiabilitiesMember
2022-06-30 0001584549
us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2021-12-31
iso4217:AUD 0001584549 vff:AtomMember
vff:ConvertiblePromissoryNoteMember 2022-02-10 0001584549
vff:AtomMember vff:ConvertiblePromissoryNoteMember 2022-02-10
2022-02-10 0001584549 vff:AtomMember
vff:ConvertiblePromissoryNoteMember 2022-06-30 0001584549
vff:VFHempMember 2022-01-01 2022-06-30 0001584549 vff:VFHempMember
2022-06-30 0001584549 vff:GridLoanAgreementMember 2021-12-31
0001584549 vff:EmployeeMember 2022-01-01 2022-06-30 0001584549
vff:EmployeeMember 2021-01-01 2021-06-30 vff:Segment 0001584549
vff:ProduceBusinessMember 2022-04-01 2022-06-30 0001584549
vff:ProduceBusinessMember 2021-04-01 2021-06-30 0001584549
vff:ProduceBusinessMember 2022-01-01 2022-06-30 0001584549
vff:ProduceBusinessMember 2021-01-01 2021-06-30 0001584549
vff:CannabisCanadaSegmentMember 2022-04-01 2022-06-30 0001584549
vff:CannabisCanadaSegmentMember 2021-04-01 2021-06-30 0001584549
vff:CannabisCanadaSegmentMember 2022-01-01 2022-06-30 0001584549
vff:CannabisCanadaSegmentMember 2021-01-01 2021-06-30 0001584549
vff:CannabisUnitedStatesSegmentMember 2022-04-01 2022-06-30
0001584549 vff:CannabisUnitedStatesSegmentMember 2022-01-01
2022-06-30 0001584549 vff:EnergyBusinessMember 2022-04-01
2022-06-30 0001584549 vff:EnergyBusinessMember 2021-04-01
2021-06-30 0001584549 vff:EnergyBusinessMember 2022-01-01
2022-06-30 0001584549 vff:EnergyBusinessMember 2021-01-01
2021-06-30 0001584549 us-gaap:EmployeeStockOptionMember 2021-12-31
0001584549 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30
0001584549 us-gaap:EmployeeStockOptionMember 2022-06-30 0001584549
us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001584549
vff:PerformanceBasedRestrictedShareUnitMember 2021-12-31 0001584549
vff:PerformanceBasedRestrictedShareUnitMember 2022-01-01 2022-06-30
0001584549 vff:PerformanceBasedRestrictedShareUnitMember 2022-06-30
0001584549 us-gaap:SubsequentEventMember vff:LeliHollandBVMember
vff:OptionAgreementMember 2022-07-19 2022-07-19 0001584549
us-gaap:SubsequentEventMember vff:LeliHollandBVMember
vff:AdditionalOwnershipMember 2022-07-19 0001584549
us-gaap:SubsequentEventMember vff:LeliHollandBVMember 2022-07-19
2022-07-19
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 10-Q
(Mark One)
☒
|
Quarterly report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
|
For the quarterly period ended June 30, 2022
☐
|
Transition report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.
|
For the transition period from
to
Commission File Number 001-38783
VILLAGE FARMS INTERNATIONAL, INC.
(Exact name of Registrant as Specified in its Charter)
Canada
|
|
98-1007671
|
(State or other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
4700-80th Street
Delta, British Columbia Canada
V4K 3N3
(Address of Principal Executive Offices) (Zip Code)
(604) 940-6012
Issuer’s phone number, including area code
N/A
(Former name, former address and former fiscal year, if changed
since last report).
Securities registered pursuant to Section 12(b) of the
Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common Shares, without par value
|
|
VFF
|
|
The Nasdaq Stock Market LLC
|
Indicate by checkmark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements
for the past 90
days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit such
files. Yes ☒ No ☐ Not
Applicable ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company or an emerging growth company. See
definition of “large accelerated filer,” “accelerated filer”,
“small reporting company” and
“emerging growth company” in Rule 12b-2 of the Exchange
Act.
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
Emerging growth company
|
|
☐
|
|
|
|
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange
Act). Yes ☐ No ☒
As of August 9, 2022, 88,571,929 shares of common stock were
outstanding.
```````1
TABLE OF CONTENTS
PART 1 – FINANCIAL STATEMENTS
Item 1. Financial Statements
Forward Looking Statement
As used in this Quarterly Report on Form 10-Q, the terms “Village
Farms”, “Village Farms International”, the “Company”, “we”, “us”,
“our” and similar references refer to Village Farms International,
Inc. and our consolidated subsidiaries, and the term “Common
Shares” refers to our common shares, no par value. Our financial
information is presented in U.S. dollars and all references in this
Quarterly Report on Form 10-Q to “$” means U.S. dollars and all
references to “C$” means Canadian dollars.
This Quarterly Report on Form 10-Q contains forward-looking
statements within the meaning of the United States Private
Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, (the “Securities Act”) and
Section 21E of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), and is subject to the safe harbor created by
those sections. This Quarterly Report on Form 10-Q also contains
“forward-looking information” within the meaning of applicable
Canadian securities law. We refer to such forward-looking
statements and forward-looking information collectively as
“forward-looking statements”. Forward-looking statements may relate
to the Company’s future outlook or financial position and
anticipated events or results and may include statements regarding
the financial position, business strategy, budgets, expansion
plans, litigation, projected production, projected costs, capital
expenditures, financial results, taxes, plans and objectives of or
involving the Company. Particularly, statements regarding future
results, performance, achievements, prospects or opportunities for
the Company, the greenhouse vegetable industry or the cannabis
industry are forward-looking statements. In some cases,
forward-looking information can be identified by such terms as
“outlook”, “may”, “might”, “will”, “could”, “should”, “would”,
“occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”,
“try”, “estimate”, “predict”, “potential”, “continue”, “likely”,
“schedule”, “objectives”, or the negative or grammatical variation
thereof or other similar expressions concerning matters that are
not historical facts. The forward-looking statements in this
Quarterly Report on Form 10-Q are subject to risks that may
include, but are not limited to: our limited operating history,
including that of Pure Sunfarms and our operations of growing hemp
in the United States; the legal status of Pure Sunfarms cannabis
business; risks relating to obtaining additional financing,
including our dependence upon credit facilities; potential
difficulties in achieving and/or maintaining profitability;
variability of product pricing; risks inherent in the cannabis,
hemp and agricultural businesses; the ability of Pure Sunfarms to
cultivate and distribute cannabis in Canada; existing and new
governmental regulations, including risks related to regulatory
compliance and licenses (e.g., Pure Sunfarms ability to maintain
licenses for its Delta 2 and Delta 3 greenhouse facilities under
the Canadian act respecting cannabis to amend to the Controlled
Drugs and Substances Act, the Criminal Code and other Acts, S.C.
2018, c. 16 (Canada)), and changes in our regulatory requirements;
risks relating to conversion of our greenhouses to cannabis
production for Pure Sunfarms; risks related to rules and
regulations at the U.S. federal (including Food and Drug
Administration and United States Department of Agriculture), state
and municipal levels with respect to produce and hemp; retail
consolidation, technological advances and other forms of
competition; transportation disruptions; product liability and
other potential litigation; retention of key executives; labor
issues; uninsured and underinsured losses; vulnerability to rising
energy costs; environmental, health and safety risks, foreign
exchange exposure, risks associated with cross-border trade;
difficulties in managing our growth; restrictive covenants under
our credit facilities; natural catastrophes; the ongoing and
developing COVID-19 pandemic; and tax risks.
The Company has based these forward-looking statements on factors
and assumptions about future events and financial trends that it
believes may affect its financial condition, results of operations,
business strategy and financial needs. Although the forward-looking
statements contained in this Quarterly Report on Form 10-Q are
based upon assumptions that management believes are reasonable
based on information currently available to management, there can
be no assurance that actual results will be consistent with these
forward-looking statements. Forward-looking statements necessarily
involve known and unknown risks and uncertainties, many of which
are beyond the Company’s control, that may cause the Company’s or
the industry’s actual results, performance, achievements, prospects
and opportunities in future periods to differ materially from those
expressed or implied by such forward-looking statements. These
risks and uncertainties include, among other things, the factors
contained in the Company’s filings with securities regulators,
including this Quarterly Report on Form 10-Q. In particular, we
caution you that our forward-looking statements are subject to the
ongoing and developing circumstances related to the COVID-19
pandemic, which may have a material adverse effect on our business,
operations and future financial results.
When relying on forward-looking statements to make decisions, the
Company cautions readers not to place undue reliance on these
statements, as forward-looking statements involve significant risks
and uncertainties and should not be read as guarantees of future
results, performance, achievements, prospects and opportunities.
The forward-looking statements made in this Quarterly Report on
Form 10-Q relate only to events or information as of the date on
which the statements are made in this Quarterly Report on Form
10-Q. Except as required by law, the Company undertakes no
obligation to update or revise publicly any forward-looking
statements, whether as a result of new information, future events
or otherwise, after the date on which the statements are made or to
reflect the occurrence of unanticipated events.
1
Village Farms International, Inc.
Condensed
Consolidated Interim Statements of Financial Position
(In thousands of United States dollars, except share data)
(Unaudited)
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
ASSETS
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
26,189
|
|
|
$
|
53,417
|
|
Restricted cash
|
|
|
6,810
|
|
|
|
5,250
|
|
Trade receivables
|
|
|
37,119
|
|
|
|
34,360
|
|
Inventories
|
|
|
76,588
|
|
|
|
68,677
|
|
Other receivables
|
|
|
506
|
|
|
|
616
|
|
Income tax receivable
|
|
|
1,831
|
|
|
|
2,430
|
|
Prepaid expenses and deposits
|
|
|
9,966
|
|
|
|
10,209
|
|
Total current assets
|
|
|
159,009
|
|
|
|
174,959
|
|
Non-current assets
|
|
|
|
|
|
|
|
|
Property, plant and equipment
|
|
|
218,004
|
|
|
|
215,704
|
|
Investment in minority interests
|
|
|
2,109
|
|
|
|
2,109
|
|
Note receivable - joint venture
|
|
|
—
|
|
|
|
3,256
|
|
Goodwill
|
|
|
92,643
|
|
|
|
117,533
|
|
Intangibles
|
|
|
20,956
|
|
|
|
26,394
|
|
Deferred tax asset
|
|
|
28,710
|
|
|
|
16,766
|
|
Right-of-use assets
|
|
|
7,224
|
|
|
|
7,609
|
|
Other assets
|
|
|
5,637
|
|
|
|
2,581
|
|
Total assets
|
|
$
|
534,292
|
|
|
$
|
566,911
|
|
LIABILITIES
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
Line of credit
|
|
$
|
6,892
|
|
|
$
|
7,760
|
|
Trade payables
|
|
|
26,634
|
|
|
|
22,597
|
|
Current maturities of long-term debt
|
|
|
10,063
|
|
|
|
11,416
|
|
Accrued sales taxes
|
|
|
13,876
|
|
|
|
3,899
|
|
Accrued loyalty program
|
|
|
1,828
|
|
|
|
2,098
|
|
Accrued liabilities
|
|
|
17,561
|
|
|
|
14,168
|
|
Lease liabilities - current
|
|
|
1,437
|
|
|
|
962
|
|
Income tax payable
|
|
|
985
|
|
|
|
—
|
|
Other current liabilities
|
|
|
1,576
|
|
|
|
1,413
|
|
Total current liabilities
|
|
|
80,852
|
|
|
|
64,313
|
|
Non-current liabilities
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
47,621
|
|
|
|
50,419
|
|
Deferred tax liability
|
|
|
17,193
|
|
|
|
18,657
|
|
Lease liabilities - non-current
|
|
|
6,383
|
|
|
|
6,711
|
|
Other liabilities
|
|
|
1,652
|
|
|
|
1,973
|
|
Total liabilities
|
|
|
153,701
|
|
|
|
142,073
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
MEZZANINE EQUITY
|
|
|
|
|
|
|
|
|
Redeemable non-controlling interest
|
|
|
16,119
|
|
|
|
16,433
|
|
SHAREHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
Common stock, no par value per share -
unlimited shares authorized; 88,571,929 shares issued and
outstanding at June 30, 2022 and 88,233,929 shares issued and
outstanding at December 31, 2021.
|
|
|
365,737
|
|
|
|
365,561
|
|
Additional paid in capital
|
|
|
11,463
|
|
|
|
9,369
|
|
Accumulated other comprehensive income
|
|
|
3,565
|
|
|
|
6,696
|
|
Retained earnings
|
|
|
(16,293
|
)
|
|
|
26,779
|
|
Total shareholders’ equity
|
|
|
364,472
|
|
|
|
408,405
|
|
Total liabilities, mezzanine equity and shareholders’ equity
|
|
$
|
534,292
|
|
|
$
|
566,911
|
|
The accompanying notes are an integral part of these Condensed
Consolidated Interim Statements of Financial Position.
2
Village Farms International, Inc.
Condensed
Consolidated Interim Statements of Loss and Comprehensive Loss
(In thousands of United States dollars, except per share data)
(Unaudited)
|
|
Three Months Ended June 30,
|
|
|
Six Months Ended June 30,
|
|
|
|
2022
|
|
|
2021
|
|
|
2022
|
|
|
2021
|
|
Sales
|
|
$
|
82,903
|
|
|
$
|
70,374
|
|
|
$
|
153,059
|
|
|
$
|
122,770
|
|
Cost of sales
|
|
|
(76,580
|
)
|
|
|
(65,109
|
)
|
|
|
(136,832
|
)
|
|
|
(115,198
|
)
|
Gross margin
|
|
|
6,323
|
|
|
|
5,265
|
|
|
|
16,227
|
|
|
|
7,572
|
|
Selling, general and administrative expenses
|
|
|
(17,402
|
)
|
|
|
(9,025
|
)
|
|
|
(34,373
|
)
|
|
|
(17,117
|
)
|
Share-based compensation
|
|
|
(1,114
|
)
|
|
|
(1,887
|
)
|
|
|
(2,078
|
)
|
|
|
(3,885
|
)
|
Interest expense
|
|
|
(665
|
)
|
|
|
(598
|
)
|
|
|
(1,348
|
)
|
|
|
(1,339
|
)
|
Interest income
|
|
|
—
|
|
|
|
46
|
|
|
|
110
|
|
|
|
49
|
|
Foreign exchange (loss) gain
|
|
|
(527
|
)
|
|
|
193
|
|
|
|
(208
|
)
|
|
|
(311
|
)
|
Other (expense) income
|
|
|
(30
|
)
|
|
|
(166
|
)
|
|
|
(38
|
)
|
|
|
(235
|
)
|
Write-off of joint venture loan
|
|
|
(592
|
)
|
|
|
—
|
|
|
|
(592
|
)
|
|
|
—
|
|
Impairments
|
|
|
(29,799
|
)
|
|
|
—
|
|
|
|
(29,799
|
)
|
|
|
—
|
|
Loss on disposal of assets
|
|
|
—
|
|
|
|
(40
|
)
|
|
|
—
|
|
|
|
(40
|
)
|
Loss before taxes and loss from equity method investments
|
|
|
(43,806
|
)
|
|
|
(6,212
|
)
|
|
|
(52,099
|
)
|
|
|
(15,306
|
)
|
Recovery of income taxes
|
|
|
9,714
|
|
|
|
1,781
|
|
|
|
11,380
|
|
|
|
3,620
|
|
Loss from equity method investments
|
|
|
(2,615
|
)
|
|
|
(86
|
)
|
|
|
(2,667
|
)
|
|
|
(213
|
)
|
Loss including non-controlling interests
|
|
|
(36,707
|
)
|
|
|
(4,517
|
)
|
|
|
(43,386
|
)
|
|
|
(11,899
|
)
|
Less: net loss attributable to non-controlling interests, net of
tax
|
|
|
152
|
|
|
|
—
|
|
|
|
314
|
|
|
|
—
|
|
Net loss attributable to Village Farms International, Inc.
|
|
$
|
(36,555
|
)
|
|
$
|
(4,517
|
)
|
|
$
|
(43,072
|
)
|
|
$
|
(11,899
|
)
|
Basic loss per share attributable to Village Farms International,
Inc. shareholders
|
|
$
|
(0.41
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.49
|
)
|
|
$
|
(0.15
|
)
|
Diluted loss per share attributable to Village Farms International,
Inc. shareholders
|
|
$
|
(0.41
|
)
|
|
$
|
(0.06
|
)
|
|
$
|
(0.49
|
)
|
|
$
|
(0.15
|
)
|
Weighted average number of common shares used in the
computation of net loss per share (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
88,567
|
|
|
|
81,071
|
|
|
|
88,472
|
|
|
|
78,560
|
|
Diluted
|
|
|
88,567
|
|
|
|
81,071
|
|
|
|
88,472
|
|
|
|
78,560
|
|
Loss including non-controlling interests
|
|
$
|
(36,707
|
)
|
|
$
|
(4,517
|
)
|
|
$
|
(43,386
|
)
|
|
$
|
(11,899
|
)
|
Less: net loss attributable to non-controlling interests, net of
tax
|
|
|
152
|
|
|
|
—
|
|
|
|
314
|
|
|
|
—
|
|
Net loss attributable to Village Farms International, Inc.
|
|
$
|
(36,555
|
)
|
|
$
|
(4,517
|
)
|
|
$
|
(43,072
|
)
|
|
$
|
(11,899
|
)
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustment
|
|
|
151
|
|
|
|
2,366
|
|
|
|
612
|
|
|
|
4,077
|
|
Comprehensive loss
|
|
$
|
(36,404
|
)
|
|
$
|
(2,151
|
)
|
|
$
|
(42,460
|
)
|
|
$
|
(7,822
|
)
|
The accompanying notes are an integral part of these Condensed
Consolidated Interim Statements of Loss and Comprehensive Loss.
3
Village Farms International, Inc.
Condensed Consolidated
Interim Statements of Changes in Shareholders’ Equity and Mezzanine
Equity
(In thousands of United States dollars, except for shares
outstanding)
(Unaudited)
|
|
Three Months Ended June 30,
|
|
|
|
Number of Common
Shares (in thousands)
|
|
|
Common Stock
|
|
|
Additional Paid in
Capital
|
|
|
Accumulated Other
Comprehensive
(Loss) Income
|
|
|
Retained Earnings
|
|
|
Total Shareholders’
Equity
|
|
|
Mezzanine Equity
|
|
Balance at April 1, 2022
|
|
|
88,562
|
|
|
$
|
365,737
|
|
|
$
|
10,333
|
|
|
$
|
10,225
|
|
|
$
|
20,262
|
|
|
$
|
406,557
|
|
|
$
|
16,271
|
|
Shares issued on exercise of stock options
|
|
|
10
|
|
|
|
—
|
|
|
|
16
|
|
|
|
—
|
|
|
|
—
|
|
|
|
16
|
|
|
|
—
|
|
Share-based compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
1,114
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,114
|
|
|
|
—
|
|
Cumulative translation adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(6,660
|
)
|
|
|
—
|
|
|
|
(6,660
|
)
|
|
|
—
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(36,555
|
)
|
|
|
(36,555
|
)
|
|
|
(152
|
)
|
Balance at June 30, 2022
|
|
|
88,572
|
|
|
$
|
365,737
|
|
|
$
|
11,463
|
|
|
$
|
3,565
|
|
|
$
|
(16,293
|
)
|
|
$
|
364,472
|
|
|
$
|
16,119
|
|
|
|
Three Months Ended June 30, 2021
|
|
|
|
Number of Common
Shares (in thousands)
|
|
|
Common Stock
|
|
|
Additional paid in
capital
|
|
|
Accumulated Other
Comprehensive Loss
|
|
|
Retained Earnings
|
|
|
Total Shareholders’
Equity
|
|
Balance at April 1, 2021
|
|
|
81,191
|
|
|
$
|
301,092
|
|
|
$
|
9,353
|
|
|
$
|
7,966
|
|
|
$
|
28,476
|
|
|
$
|
346,887
|
|
Shares issued on exercise of warrants
|
|
|
143
|
|
|
|
1,307
|
|
|
|
(475
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
832
|
|
Shares issued on exercise of stock options
|
|
|
58
|
|
|
|
98
|
|
|
|
(37
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
61
|
|
Share re-purchases
|
|
|
(428
|
)
|
|
|
—
|
|
|
|
(3,980
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,980
|
)
|
Share-based compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
1,887
|
|
|
|
—
|
|
|
|
—
|
|
|
|
1,887
|
|
Cumulative translation adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,366
|
|
|
|
—
|
|
|
|
2,366
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(4,517
|
)
|
|
|
(4,517
|
)
|
Balance at June 30, 2021
|
|
|
80,964
|
|
|
$
|
302,497
|
|
|
$
|
6,748
|
|
|
$
|
10,332
|
|
|
$
|
23,959
|
|
|
$
|
343,536
|
|
|
|
Six Months Ended June 30, 2022
|
|
|
|
|
|
|
|
Number of
Common
Shares
|
|
|
Common
Stock
|
|
|
Additional
paid in
capital
|
|
|
Accumulated
Other
Comprehensive
Loss
|
|
|
Retained
Earnings
|
|
|
Total
Shareholders’
Equity
|
|
|
Mezzanine Equity
|
|
Balance at January 1, 2022
|
|
|
88,234
|
|
|
$
|
365,561
|
|
|
$
|
9,369
|
|
|
$
|
6,696
|
|
|
$
|
26,779
|
|
|
$
|
408,405
|
|
|
$
|
16,433
|
|
Shares issued on exercise of stock options
|
|
|
338
|
|
|
|
176
|
|
|
|
16
|
|
|
|
—
|
|
|
|
—
|
|
|
|
192
|
|
|
|
—
|
|
Share-based compensation
|
|
|
—
|
|
|
|
—
|
|
|
|
2,078
|
|
|
|
—
|
|
|
|
—
|
|
|
|
2,078
|
|
|
|
—
|
|
Cumulative translation adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,131
|
)
|
|
|
—
|
|
|
|
(3,131
|
)
|
|
|
—
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(43,072
|
)
|
|
|
(43,072
|
)
|
|
|
(314
|
)
|
Balance at June 30, 2022
|
|
|
88,572
|
|
|
$
|
365,737
|
|
|
$
|
11,463
|
|
|
$
|
3,565
|
|
|
$
|
(16,293
|
)
|
|
$
|
364,472
|
|
|
$
|
16,119
|
|
|
|
Six Months Ended June 30, 2021
|
|
|
|
Number of
Common
Shares
|
|
|
Common
Stock
|
|
|
Additional paid
in capital
|
|
|
Accumulated Other
Comprehensive
(Loss) Income
|
|
|
Retained
Earnings
|
|
|
Total
Shareholders’
Equity
|
|
Balance at January 1, 2021
|
|
|
66,912
|
|
|
$
|
145,668
|
|
|
$
|
17,502
|
|
|
$
|
6,255
|
|
|
$
|
35,858
|
|
|
$
|
205,283
|
|
Shares issued in public offering, net of issuance costs
|
|
|
10,887
|
|
|
|
127,489
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
127,489
|
|
Warrants issued in public offering
|
|
|
3,188
|
|
|
|
29,050
|
|
|
|
(10,555
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
18,495
|
|
Shares issued on exercise of stock options
|
|
|
162
|
|
|
|
290
|
|
|
|
(104
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
186
|
|
Share re-purchases
|
|
|
(428
|
)
|
|
|
—
|
|
|
|
(3,980
|
)
|
|
|
—
|
|
|
|
—
|
|
|
|
(3,980
|
)
|
Share-based compensation
|
|
|
243
|
|
|
|
—
|
|
|
|
3,885
|
|
|
|
—
|
|
|
|
—
|
|
|
|
3,885
|
|
Cumulative translation adjustment
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
4,077
|
|
|
|
—
|
|
|
|
4,077
|
|
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
(11,899
|
)
|
|
|
(11,899
|
)
|
Balance at June 30, 2021
|
|
|
80,964
|
|
|
$
|
302,497
|
|
|
$
|
6,748
|
|
|
$
|
10,332
|
|
|
$
|
23,959
|
|
|
$
|
343,536
|
|
The accompanying notes are an integral part of these Condensed
Consolidated Interim Statements of Changes in Shareholders’ Equity
and Mezzanine Equity.
4
Village Farms International, Inc.
Condensed Consolidated Interim Statements of Cash Flows
(In thousands of United States dollars)
(Unaudited)
|
|
Six Months Ended June 30,
|
|
|
|
2022
|
|
|
2021
|
|
Cash flows used in operating activities:
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(43,072
|
)
|
|
$
|
(11,899
|
)
|
Adjustments to reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
6,332
|
|
|
|
6,536
|
|
Amortization of deferred charges
|
|
|
126
|
|
|
|
166
|
|
Share of loss from joint ventures
|
|
|
2,667
|
|
|
|
213
|
|
Interest expense
|
|
|
1,348
|
|
|
|
1,339
|
|
Interest income
|
|
|
(110
|
)
|
|
|
(49
|
)
|
Interest paid on long-term debt
|
|
|
(1,855
|
)
|
|
|
(1,909
|
)
|
Unrealized foreign exchange gain/loss
|
|
|
115
|
|
|
|
161
|
|
Impairments
|
|
|
29,799
|
|
|
|
—
|
|
Write-off of joint venture loan
|
|
|
592
|
|
|
|
—
|
|
Loss on disposal of assets
|
|
|
—
|
|
|
|
40
|
|
Non-cash lease expense
|
|
|
29
|
|
|
|
(255
|
)
|
Share-based compensation
|
|
|
2,078
|
|
|
|
3,885
|
|
Deferred income taxes
|
|
|
(16,134
|
)
|
|
|
(3,199
|
)
|
Changes in non-cash working capital items
|
|
|
9,064
|
|
|
|
(10,239
|
)
|
Net cash used in operating activities
|
|
|
(9,021
|
)
|
|
|
(15,210
|
)
|
Cash flows used in investing activities:
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
|
(10,232
|
)
|
|
|
(11,355
|
)
|
Advances to joint ventures
|
|
|
—
|
|
|
|
(12
|
)
|
Notes receivable
|
|
|
(3,449
|
)
|
|
|
(1,001
|
)
|
Net cash used in investing activities
|
|
|
(13,681
|
)
|
|
|
(12,368
|
)
|
Cash flows provided by financing activities:
|
|
|
|
|
|
|
|
|
Proceeds from borrowings
|
|
|
4,000
|
|
|
|
4,227
|
|
Repayments on borrowings
|
|
|
(6,490
|
)
|
|
|
(6,026
|
)
|
Proceeds from issuance of common stock and warrants
|
|
|
—
|
|
|
|
135,000
|
|
Issuance costs
|
|
|
—
|
|
|
|
(7,511
|
)
|
Proceeds from exercise of stock options
|
|
|
192
|
|
|
|
186
|
|
Proceeds from exercise of warrants
|
|
|
—
|
|
|
|
18,495
|
|
Share re-purchases
|
|
|
—
|
|
|
|
(3,980
|
)
|
Payments on capital lease obligations
|
|
|
(612
|
)
|
|
|
(310
|
)
|
Payment of note payable related to acquisition
|
|
|
—
|
|
|
|
(15,498
|
)
|
Net cash (used in) provided by financing activities
|
|
|
(2,910
|
)
|
|
|
124,583
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
(56
|
)
|
|
|
502
|
|
Net (decrease) increase in cash and cash equivalents
|
|
|
(25,668
|
)
|
|
|
97,507
|
|
Cash and cash equivalents, beginning of period
|
|
|
58,667
|
|
|
|
25,679
|
|
Cash and cash equivalents, end of period
|
|
$
|
32,999
|
|
|
$
|
123,186
|
|
The accompanying notes are an integral part of these Condensed
Consolidated Interim Statements of Cash Flows.
5
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements
(In thousands of United States dollars, except per share amounts,
unless otherwise noted)
1
|
DESCRIPTION OF BUSINESS
|
Village Farms International, Inc. (“VFF” and, together with its
subsidiaries, the “Company”, “we”, “us”, or “our”) is incorporated
under the Canada Business Corporations Act. VFF’s principal
operating subsidiaries as of June 30, 2022 are Village Farms
Canada Limited Partnership, Village Farms, L.P., Pure Sunfarms
Corp. (“Pure Sunfarms”), and Balanced Health Botanicals, LLC
(“Balanced Health”). VFF also owns a 70% interest in Rose
LifeScience Inc. (“Rose”).
The address of the registered office of VFF is 4700-80th Street,
Delta, British Columbia, Canada, V4K 3N3.
The Company’s shares are listed on Nasdaq Capital Market (“Nasdaq”)
under the symbol “VFF”.
Village Farms owns and operates sophisticated, highly intensive
agricultural greenhouse facilities in British Columbia and Texas,
where it produces, markets and sells premium-quality tomatoes, bell
peppers, and cucumbers. Its wholly owned subsidiary, Pure Sunfarms,
is a vertically integrated licensed producer and supplier of
cannabis products to be sold to other licensed providers and
provincial governments across Canada and internationally. Through
its 70% ownership of Rose, the Company has a substantial presence
in the Province of Quebec as a cannabis supplier, producer and
commercialization expert. The Company’s wholly owned subsidiary,
Balance Health, develops and sells high-quality, cannabidiol
(“CBD”) based products including ingestible, edible and topical
applications.
The accompanying unaudited Condensed Consolidated Interim Financial
Statements for the three and six months ended June 30, 2022
have been prepared in accordance with accounting principles
generally accepted in the United States for interim financial
information and with the instructions to Form 10-Q and Rule 10-01
of Regulation S-X. They do not include all information and notes
required by generally accepted accounting principles for complete
financial statements. In the opinion of management, all adjustments
of a normal recurring nature considered necessary for fair
presentation have been included. Operating results for the three
and six months ended June 30, 2022 are subject to seasonal
variations and accordingly are not necessarily indicative of the
results that may be expected for the year ending December 31,
2022. For further information, refer to the Consolidated Financial
Statements and notes thereto included in our Annual Report on Form
10-K for the fiscal years ended December 31, 2021 and
2020.
In the opinion of management, these financial statements include
all adjustments, which are of a normal recurring nature, necessary
for a fair statement of the financial position, results of
operations, comprehensive loss, cash flows and the change in equity
for the periods presented.
There have been no changes to our significant accounting policies
described in the Annual Report on Form 10-K for the year ended
December 31, 2021 filed with the SEC on March 1, 2022 that have had
a material impact on our condensed consolidated interim financial
statements and related notes.
The condensed consolidated interim financial statements reflect the
accounts of the Company and its majority-owned and controlled
subsidiaries. All intercompany accounts and transactions between
our consolidated operations have been eliminated.
3
|
NEW ACCOUNTING PRONOUNCEMENTS
|
In March 2020, the Financial Accounting Standards Board (“FASB”)
issued Accounting Standards Update (“ASU”) 2020-04, Reference Rate Reform (Topic 848):
Facilitation of the Effects of Reference Rate Reform on Financial
Reporting (“ASU 2020-04”). ASU 2020-04 provides
optional expedients and exceptions for applying GAAP to debt
instruments, derivatives, and other contracts that reference LIBOR
or other reference rates expected to be discontinued as a result of
reference rate reform. This guidance is optional and may be elected
through December 31, 2022 using a prospective application on all
eligible contract modifications. The Company has a line of credit
that incorporates LIBOR as a referenced interest rate. It is
difficult to predict what effect, if any, the phase-out of LIBOR
and the use of alternative benchmarks may have on the Company’s
business or on the overall financial markets. The Company has not
adopted any of the optional expedients or exceptions
through June 30, 2022
but will continue to evaluate
the possible adoption of any such expedients or
exceptions.
6
VILLAGE FARMS INTERNATIONAL, INC.
Notes to Condensed Consolidated Interim Financial Statements
(In thousands of United States dollars, except per share amounts,
unless otherwise noted)
Inventories consisted of the following as of:
Classification
|
|
June 30, 2022
|
|
|
December 31, 2021
|
|
Cannabis:
|
|
|
|
|
|
|
|
|
Raw materials
|
|
$
|
1,814
|
|
|
$
|
2,071
|
|
Work-in-progress
|
|
|
8,245
|
|
|
|
5,056
|
|
Finished goods
|
|
|
45,907
|
|
|
|
32,161
|
|
Packaging
|
|
|
5,927
|
|
|
|
5,877
|
|
|